Skip to main content
SpringerLink
Log in

Probiotics for Diarrheal Diseases

  • Chapter
  • First Online:
Diarrhea

Part of the book series: Clinical Gastroenterology ((CG))

  • 1985 Accesses

Summary

In recent years, a large body of literature has been generated on the use of probiotics. Regarded initially as alternative medicine, probiotics – mostly lactic acid bacteria – has gained their position in mainstream medicine, after a robust research activity covering both in vitro and in vivo studies, as well as randomized clinical trials. In terms of diarrheal diseases, the most promising applications appear in the prevention and/or the treatment of acute gastroenteritis, antibiotic-associated diarrhea, neonatal-necrotizing enterocolitis, and ulcerative colitis. It should be kept in mind that different strains of probiotics have different specificities, so no generalizations on the efficacy (or lack thereof) of “probiotics” should be made. This chapter will analyze the evidence for the use of probiotics in such diarrheal diseases; in some cases this is quite consolidated, in others still emerging.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Guandalini S. An update on the role of probiotics in the therapy of pediatric inflammatory bowel disease. Exp Rev Clin Immunol 2010;6:47–54.

    Article  CAS  Google Scholar 

  2. Oberhelman RA, et al. A placebo-controlled trial of Lactobacillus GG to prevent diarrhea in undernourished Peruvian children. J Pediatr 1999;134(1):15–20.

    Article  PubMed  CAS  Google Scholar 

  3. Pereg D, et al. The effect of fermented yogurt on the prevention of diarrhea in a healthy adult population. Am J Infect Control 2005;33(2):122–125.

    Article  PubMed  Google Scholar 

  4. Pedone CA, et al. Multicentric study of the effect of milk fermented by Lactobacillus casei on the incidence of diarrhoea. Int J Clin Pract 2000;54(9):568–571.

    PubMed  CAS  Google Scholar 

  5. Hatakka K, et al. Effect of long term consumption of probiotic milk on infections in children attending day care centres: double blind, randomised trial. BMJ 2001:322(7298):1327.

    Article  PubMed  CAS  Google Scholar 

  6. Thibault H, Aubert-Jacquin C, Goulet O. Effects of long-term consumption of a fermented infant formula (with Bifidobacterium breve c50 and Streptococcus thermophilus 065) on acute diarrhea in healthy infants. J Pediatr Gastroenterol Nutr 2004;39(2):147–152.

    Article  PubMed  CAS  Google Scholar 

  7. Chouraqui JP, Van Egroo LD, Fichot MC. Acidified milk formula supplemented with Bifidobacterium lactis: impact on infant diarrhea in residential care settings. J Pediatr Gastroenterol Nutr 2004:38(3):288–292.

    Article  PubMed  Google Scholar 

  8. Saavedra JM, et al. Long-term consumption of infant formulas containing live probiotic bacteria: tolerance and safety. Am J Clin Nutr 2004;79(2):261–267.

    PubMed  CAS  Google Scholar 

  9. Weizman Z, Asli G, Alsheikh A. Effect of a probiotic infant formula on infections in child care centers: comparison of two probiotic agents. Pediatrics 2005;115(1):5–9.

    PubMed  Google Scholar 

  10. Binns CW, et al. The CUPDAY Study: prebiotic–probiotic milk product in 1–3-year-old children attending childcare centres. Acta Paediatr 2007:96(11):1646–1650.

    Article  PubMed  CAS  Google Scholar 

  11. Mastretta E, et al. Effect of Lactobacillus GG and breast-feeding in the prevention of rotavirus nosocomial infection. J Pediatr Gastroenterol Nutr 2002;35(4):527–531.

    Article  PubMed  Google Scholar 

  12. Saavedra JM, et al. Feeding of Bifidobacterium bifidum and Streptococcus thermophilus to infants in hospital for prevention of diarrhoea and shedding of rotavirus. Lancet 1994;344(8929):1046–1049.

    Article  PubMed  CAS  Google Scholar 

  13. Szajewska H, et al. Efficacy of Lactobacillus GG in prevention of nosocomial diarrhea in infants. J Pediatr 2001;138(3):361–365.

    Article  PubMed  CAS  Google Scholar 

  14. McFarland LV. Meta-analysis of probiotics for the prevention of traveler’s diarrhea. Travel Med Infect Dis 2007;5(2):97–105.

    Article  PubMed  Google Scholar 

  15. Basu S, et al. Efficacy of high-dose Lactobacillus rhamnosus GG in controlling acute watery diarrhea in Indian children: a randomized controlled trial. J Clin Gastroenterol 2009:43(3):208–213.

    Article  PubMed  Google Scholar 

  16. Basu S, et al. Efficacy of Lactobacillus rhamnosus GG in acute watery diarrhoea of Indian children: a randomised controlled trial. J Paediatr Child Health 2007;43(12):837–842.

    Article  PubMed  Google Scholar 

  17. Canani RB, et al. Probiotics for treatment of acute diarrhoea in children: randomised clinical trial of five different preparations. BMJ 2007;335(7615):340.

    Article  PubMed  Google Scholar 

  18. Fang SB, et al. Dose-dependent effect of Lactobacillus rhamnosus on quantitative reduction of faecal rotavirus shedding in children. J Trop Pediatr 2009;55(5):297–301.

    Article  PubMed  Google Scholar 

  19. Guandalini S, et al. Lactobacillus GG administered in oral rehydration solution to children with acute diarrhea: a multicenter European trial. J Pediatr Gastroenterol Nutr 2000;30(1):54–60.

    Article  PubMed  CAS  Google Scholar 

  20. Guarino A, et al. Oral bacterial therapy reduces the duration of symptoms and of viral excretion in children with mild diarrhea. J Pediatr Gastroenterol Nutr 1997;25(5):516–519.

    Article  PubMed  CAS  Google Scholar 

  21. Isolauri E, et al. A human Lactobacillus strain (Lactobacillus casei sp strain GG) promotes recovery from acute diarrhea in children. Pediatrics 1991;88(1):90–97.

    PubMed  CAS  Google Scholar 

  22. Isolauri E, et al. Oral bacteriotherapy for viral gastroenteritis. Dig Dis Sci 1994;39(12):2595–2600.

    Article  PubMed  CAS  Google Scholar 

  23. Kaila M, et al. Viable versus inactivated lactobacillus strain GG in acute rotavirus diarrhoea. Arch Dis Child 1995;72(1):51–53.

    Article  PubMed  CAS  Google Scholar 

  24. Kaila M, et al. Enhancement of the circulating antibody secreting cell response in human diarrhea by a human Lactobacillus strain. Pediatr Res 1992;32(2):141–144.

    Article  PubMed  CAS  Google Scholar 

  25. Majamaa H, et al. Lactic acid bacteria in the treatment of acute rotavirus gastroenteritis. J Pediatr Gastroenterol Nutr 1995;20(3):333–338.

    Article  PubMed  CAS  Google Scholar 

  26. Pant AR, et al. Lactobacillus GG and acute diarrhoea in young children in the tropics. J Trop Pediatr 1996;42(3):162–165.

    Article  PubMed  CAS  Google Scholar 

  27. Rautanen T, et al. Management of acute diarrhoea with low osmolarity oral rehydration solutions and Lactobacillus strain GG. Arch Dis Child 1998;79(2):157–160.

    Article  PubMed  CAS  Google Scholar 

  28. Raza S, et al. Lactobacillus GG in acute diarrhea. Indian Pediatr 1995;32(10):1140–1142.

    PubMed  CAS  Google Scholar 

  29. Raza S, et al. Lactobacillus GG promotes recovery from acute nonbloody diarrhea in Pakistan. Pediatr Infect Dis J 1995;14(2):107–111.

    Article  PubMed  CAS  Google Scholar 

  30. Shornikova AV, et al. Bacteriotherapy with Lactobacillus reuteri in rotavirus gastroenteritis. Pediatr Infect Dis J 1997;16(12):1103–1107.

    Article  PubMed  CAS  Google Scholar 

  31. Misra S, Sabui TK, Pal NK. A randomized controlled trial to evaluate the efficacy of lactobacillus GG in infantile diarrhea. J Pediatr 2009;155(1):129–132.

    Article  PubMed  Google Scholar 

  32. Billoo AG, et al. Role of a probiotic (Saccharomyces boulardii) in management and prevention of diarrhoea. World J Gastroenterol 2006;12(28):4557–4560.

    PubMed  CAS  Google Scholar 

  33. Htwe K, et al. Effect of Saccharomyces boulardii in the treatment of acute watery diarrhea in Myanmar children: a randomized controlled study. Am J Trop Med Hyg 2008;78(2):214–216.

    PubMed  Google Scholar 

  34. Kurugol Z, Koturoglu G. Effects of Saccharomyces boulardii in children with acute diarrhoea. Acta Paediatr 2005;94(1):44–47.

    Article  PubMed  CAS  Google Scholar 

  35. Ozkan TB, et al. Effect of Saccharomyces boulardii in children with acute gastroenteritis and its relationship to the immune response. J Int Med Res 2007;35(2):201–212.

    PubMed  CAS  Google Scholar 

  36. Villarruel G, et al. Saccharomyces boulardii in acute childhood diarrhoea: a randomized, placebo-controlled study. Acta Paediatr 2007;96(4):538–541.

    Article  PubMed  Google Scholar 

  37. Anukam KC, et al. Yogurt containing probiotic Lactobacillus rhamnosus GR-1 and L. reuteri RC-14 helps resolve moderate diarrhea and increases CD4 count in HIV/AIDS patients. J Clin Gastroenterol 2008;42(3):239–243.

    PubMed  Google Scholar 

  38. Rosenfeldt V, et al. Effect of probiotic Lactobacillus strains on acute diarrhea in a cohort of nonhospitalized children attending day-care centers. Pediatr Infect Dis J 2002;21(5):417–419.

    Article  PubMed  Google Scholar 

  39. Rosenfeldt V, et al. Effect of probiotic Lactobacillus strains in young children hospitalized with acute diarrhea. Pediatr Infect Dis J 2002;21(5):411–416.

    Article  PubMed  Google Scholar 

  40. Shornikova AV, et al. Lactobacillus reuteri as a therapeutic agent in acute diarrhea in young children. J Pediatr Gastroenterol Nutr 1997;24(4):399–404.

    Article  PubMed  CAS  Google Scholar 

  41. Henker J, et al. The probiotic Escherichia coli strain Nissle 1917 (EcN) stops acute diarrhoea in infants and toddlers. Eur J Pediatr 2007;166(4):311–318.

    Article  PubMed  Google Scholar 

  42. Henker J, et al. Probiotic Escherichia coli Nissle 1917 versus placebo for treating diarrhea of greater than 4 days duration in infants and toddlers. Pediatr Infect Dis J 2008;27(6):494–499.

    Article  PubMed  Google Scholar 

  43. Lievin-Le Moal V, Sarrazin-Davila LE, Servin AL. An experimental study and a randomized, double-blind, placebo-controlled clinical trial to evaluate the antisecretory activity of Lactobacillus acidophilus strain LB against nonrotavirus diarrhea. Pediatrics 2007;120(4):e795–e803.

    Article  PubMed  Google Scholar 

  44. Salazar-Lindo E, et al. Effectiveness and safety of Lactobacillus LB in the treatment of mild acute diarrhea in children. J Pediatr Gastroenterol Nutr 2007;44(5):571–576.

    Article  PubMed  Google Scholar 

  45. Dubey AP, et al. Use of VSL[sharp]3 in the treatment of rotavirus diarrhea in children: preliminary results. J Clin Gastroenterol 2008;42(Suppl 3 Pt 1):S126–S129.

    Article  PubMed  Google Scholar 

  46. Szajewska H, et al. Meta-analysis: Lactobacillus GG for treating acute diarrhoea in children. Aliment Pharmacol Ther 2007;25(8):871–881.

    Article  PubMed  CAS  Google Scholar 

  47. Vandenplas Y, Brunser O, Szajewska H. Saccharomyces boulardii in childhood. Eur J Pediatr 2009;168(3):253–265.

    Article  PubMed  Google Scholar 

  48. Szajewska H, Skorka A, Dylag M. Meta-analysis: Saccharomyces boulardii for treating acute diarrhoea in children. Aliment Pharmacol Ther 2007;25(3):257–264.

    Article  PubMed  CAS  Google Scholar 

  49. Hauck FH, et al. Imerslund-Grasbeck syndrome in a 15-year-old German girl caused by compound heterozygous mutations in CUBN. Eur J Pediatr 2008;167(6):671–675.

    Article  PubMed  Google Scholar 

  50. Gaon D, et al. Effect of Lactobacillus strains and Saccharomyces boulardii on persistent diarrhea in children. Medicina (B Aires) 2003;63(4):293–298.

    Google Scholar 

  51. Alfaleh K, Anabrees J, Bassler D. Probiotics reduce the risk of necrotizing enterocolitis in preterm infants: a meta-analysis. Neonatology 2009;97:93–99.

    Article  PubMed  Google Scholar 

  52. Lin H, et al. Oral probiotics prevent necrotizing enterocolitis in very low birth weight preterm infants: a multicenter, randomized, controlled trial. Pediatrics 2008;122:693–700.

    Article  PubMed  Google Scholar 

  53. Vanderpool C, Yan F, Polk DB. Mechanisms of probiotic action: implications for therapeutic applications in inflammatory bowel diseases. Inflamm Bowel Dis 2008;14(11):1585–1596.

    Article  PubMed  Google Scholar 

  54. Butterworth AD, Thomas AG, Akobeng AK. Probiotics for induction of remission in Crohn’s disease. Cochrane Database Syst Rev 2008(3):CD006634.

    Google Scholar 

  55. Pastorelli L, et al. Emerging drugs for the treatment of ulcerative colitis. Expert Opin Emerg Drugs 2009;14(3):505–521.

    Article  PubMed  CAS  Google Scholar 

  56. Miele E, et al. Effect of a probiotic preparation (VSL#3) on induction and maintenance of remission in children with ulcerative colitis. Am J Gastroenterol 2009;104(2):437–443.

    Article  PubMed  CAS  Google Scholar 

  57. Sood A, et al. The probiotic preparation, VSL#3 induces remission in patients with mild-to-moderately active ulcerative colitis. Clin Gastroenterol Hepatol 2009;7(11):1202–1209.

    Article  PubMed  Google Scholar 

  58. Guandalini S, et al. VSL#3 improves symptoms in children with irritable bowel syndrome. A multicenter, randomized, placebo-controlled, double-blind, cross-over study. J Pediatr Gastroenterol Nutr 2010;51:24–30.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. University of Chicago Comer Children’s Hospital, 5841 S. Maryland Ave., MC 4065, Chicago, IL, USA

    Stefano Guandalini MD

Authors
  1. Stefano Guandalini MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Celiac Disease Center, Div. Pediatric Gastroenterology,, University of Chicago, S. Maryland Ave. 5839, Chicago, 60637, Illinois, USA

    Stefano Guandalini

  2. Health Center, Div. Gastroenterology, University of Connecticut, Farmington Ave. 263, Farmington, 06030-1845, Connecticut, USA

    Haleh Vaziri

Rights and permissions

Reprints and permissions

Copyright information

© 2010 Springer Science+Business Media, LLC

About this chapter

Cite this chapter

Guandalini, S. (2010). Probiotics for Diarrheal Diseases. In: Guandalini, S., Vaziri, H. (eds) Diarrhea. Clinical Gastroenterology. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-60761-183-7_27

Download citation

  • DOI: https://doi.org/10.1007/978-1-60761-183-7_27

  • Published:

  • Publisher Name: Humana Press, Totowa, NJ

  • Print ISBN: 978-1-60761-182-0

  • Online ISBN: 978-1-60761-183-7

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation